Plant ID: NPO21995
Plant Latin Name: Gelsemium elegans
Taxonomy Genus: Gelsemium
Taxonomy Family: Gelsemiaceae
NCBI TaxonomyDB:
427660
Plant-of-the-World-Online:
546348-1
Myanmar; Indonesia; India; Vietnam; China; Laos; Thailand
TDP1; HPGD; | |
CREBBP; | |
MAPT; HTT; LMNA; |
Protein Class | Gene ID | Protein Name | Uniprot ID | Target ChEMBL ID |
---|---|---|---|---|
Bromodomain | CREBBP | CREB-binding protein | Q92793 | CHEMBL5747 |
Cytochrome P450 family 2 | CYP2D6 | Cytochrome P450 2D6 | P10635 | CHEMBL289 |
Cytochrome P450 family 3 | CYP3A4 | Cytochrome P450 3A4 | P08684 | CHEMBL340 |
Enzyme_unclassified | TDP1 | Tyrosyl-DNA phosphodiesterase 1 | Q9NUW8 | CHEMBL1075138 |
Enzyme_unclassified | HPGD | 15-hydroxyprostaglandin dehydrogenase [NAD+] | P15428 | CHEMBL1293255 |
Unclassified | MAPT | Microtubule-associated protein tau | P10636 | CHEMBL1293224 |
Unclassified | HTT | Huntingtin | P42858 | CHEMBL5514 |
Unclassified | LMNA | Prelamin-A/C | P02545 | CHEMBL1293235 |
GO Type | GO Category | Enriched GO Terms | p-Value | Adjusted p-Value | Enriched Genes |
---|---|---|---|---|---|
BP | GO:0008152; metabolic process | GO:0009822; alkaloid catabolic process | 4.502E-07 | 9.803E-03 | CYP2D6, CYP3A4 |
BP | GO:0008152; metabolic process | GO:0016098; monoterpenoid metabolic process | 2.250E-06 | 2.286E-02 | CYP2D6, CYP3A4 |
BP | GO:0008152; metabolic process | GO:0070989; oxidative demethylation | 9.886E-06 | 4.305E-02 | CYP2D6, CYP3A4 |
MF | GO:0005488; binding | GO:0034452; dynactin binding | 8.240E-06 | 4.305E-02 | HTT, MAPT |
MF | GO:0003824; catalytic activity | GO:0070330; aromatase activity | 3.781E-05 | 1.372E-01 | CYP2D6, CYP3A4 |
BP | GO:0009987; cellular process | GO:0010821; regulation of mitochondrion organization | 8.476E-05 | 2.051E-01 | HTT, LMNA, MAPT |
BP | GO:0065007; biological regulation | GO:0031648; protein destabilization | 1.282E-04 | 2.467E-01 | CREBBP, HTT |
BP | GO:0009987; cellular process | GO:0042981; regulation of apoptotic process | 1.325E-04 | 2.467E-01 | CREBBP, HPGD, HTT, LMNA, MAPT |
MF | GO:0005488; binding | GO:0019825; oxygen binding | 1.473E-04 | 2.467E-01 | CYP2D6, CYP3A4 |
CC | GO:0043226; organelle | GO:0016604; nuclear body | 2.450E-03 | 5.751E-01 | CREBBP, LMNA, MAPT |
CC | GO:0044464; cell part | GO:0030424; axon | 4.683E-03 | 7.531E-01 | HTT, MAPT |
CC | GO:0044464; cell part | GO:0030673; axolemma | 6.609E-03 | 8.951E-01 | MAPT |
CC | GO:0044464; cell part | GO:0030425; dendrite | 7.791E-03 | 9.649E-01 | HTT, MAPT |
Pathway Category Top Level | Pathway Category Second Level | Pathway ID | Pathway Name | p-Value | Adjusted p-Value | Enriched Genes |
---|---|---|---|---|---|---|
09100 Metabolism | 09111 Xenobiotics biodegradation and metabolism | hsa00982 | Drug metabolism - cytochrome P450 | 3.241E-04 | 7.618E-03 | CYP2D6, CYP3A4 |
09100 Metabolism | 09111 Xenobiotics biodegradation and metabolism | hsa00980 | Metabolism of xenobiotics by cytochrome P450 | 3.627E-04 | 7.618E-03 | CYP2D6, CYP3A4 |
09160 Human Diseases | 09163 Neurodegenerative diseases | hsa05016 | Huntington's disease | 2.497E-03 | 3.495E-02 | CREBBP, HTT |
09100 Metabolism | 09103 Lipid metabolism | hsa00591 | Linoleic acid metabolism | 1.154E-02 | 8.094E-02 | CYP3A4 |
09100 Metabolism | 09111 Xenobiotics biodegradation and metabolism | hsa00983 | Drug metabolism - other enzymes | 1.826E-02 | 8.094E-02 | CYP3A4 |
09130 Environmental Information Processing | 09132 Signal transduction | hsa04330 | Notch signaling pathway | 1.904E-02 | 8.094E-02 | CREBBP |
09150 Organismal Systems | 09156 Nervous system | hsa04720 | Long-term potentiation | 2.610E-02 | 8.094E-02 | CREBBP |
09150 Organismal Systems | 09152 Endocrine system | hsa04916 | Melanogenesis | 3.931E-02 | 8.094E-02 | CREBBP |
09160 Human Diseases | 09165 Cardiovascular diseases | hsa05414 | Dilated cardiomyopathy | 3.544E-02 | 8.094E-02 | LMNA |
09130 Environmental Information Processing | 09132 Signal transduction | hsa04066 | HIF-1 signaling pathway | 4.047E-02 | 8.094E-02 | CREBBP |